Dow Up0.07% Nasdaq Up0.61%

Pernix Therapeutics Holdings, Inc. (PTX)

-NGM
10.66 Up 0.04(0.38%) Nov 26, 4:00PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (25,635) (1,410) 8,348  
Operating Activities, Cash Flows Provided By or Used In
Depreciation9,857  3,201  2,303  
Adjustments To Net Income(12,714)1,769  517  
Changes In Accounts Receivables12,163  (3,886)(5,843)
Changes In Liabilities4,457  (770)6,463  
Changes In Inventories7,406  (650)(2,115)
Changes In Other Operating Activities(1,538)(1,515)(2,512)
Total Cash Flow From Operating Activities (6,532) (1,926) 9,397  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(528)(326)(176)
Investments4,296  (56,328)(2,000)
Other Cash flows from Investing Activities19,620  (8,242)(1,000)
Total Cash Flows From Investing Activities 23,388   (64,897) (2,176)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock261  24,586  19,549  
Net Borrowings(26,997)30,394  383  
Other Cash Flows from Financing Activities2,504  315  (863)
Total Cash Flows From Financing Activities (24,231) 55,294   19,069  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (7,376) (11,528) 26,291  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.